Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
Clinical trial NCT07210047 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07210047
- Sponsor
- HuniLife Biotechnology, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2027-11-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.